Sotatercept Use in a Patient with Pulmonary Arterial Hypertension Undergoing Lung Transplantation
Pulmonary arterial hypertension (PAH) is one of the common indications for lung transplantation. Sotatercept is a new medication with a novel mechanism of action and was recently approved for the treatment of PAH. Sotatercept is associated with significant adverse effects including thrombocytopenia...
Tallennettuna:
| Päätekijät: | , , , , , , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Elsevier
2025-05-01
|
| Sarja: | JHLT Open |
| Aiheet: | |
| Linkit: | http://www.sciencedirect.com/science/article/pii/S2950133425000084 |
| Tagit: |
Ei tageja, Lisää ensimmäinen tagi!
|